Leveraging Expert-Curated Knowledge from COSMIC and QIAGEN to Avoid Pitfalls, Qualify Candidate Drug Targets, and Accelerate Early Discovery

Learn how to accelerate cancer drug discovery by leveraging expert-curated genomic databases and avoiding common research pitfalls in this 46-minute webinar presented by Dr. Kyle Nilson from QIAGEN Digital Insights. Discover strategies for improving biopharmaceutical research efficiency while reducing costs and complexity in an increasingly fast-paced development environment. Explore how to utilize key genomic, biomedical, and clinical trial databases from the Wellcome Sanger Institute and QIAGEN to enhance cancer drug discovery processes. Master techniques for predicting cancer-driving effects of mutations using expert-curated knowledge from COSMIC and QIAGEN resources. Understand methods for identifying available drugs that target specific genetic variants and accelerating indication expansion opportunities. Examine practical use cases demonstrating how to repurpose existing cancer therapies more effectively. Gain insights into qualifying candidate drug targets through comprehensive database analysis and expert-curated information. Access proven approaches for streamlining early discovery phases while maintaining research quality and safety standards.